Orphan Disease Center -- IQSEC2 Research and Advocacy Foundation Research Grant Program 2023

Funding Agency:
University of Pennsylvania

The IQSEC2 Research and Advocacy Foundation will provide a 1-year grant, with a no cost extension of up to one year granted with approval, to support research related to IQSEC2-related disorder. The foundation will award either one grant of $60,000 or two grants for $30,000.

The IQSEC2 Research and Advocacy Foundation, in collaboration with the Orphan Disease Center, is seeking grant applications that will address both symptoms of the disease (i.e. intractable seizures) and/or mechanistic studies that are oriented towards developing therapies addressing the underlying cause of IQSEC2 mediated intellectual disability, autism and epilepsy. The grant will exclusively be on IQSEC2 mutation mediated disease and not on other disease mutations that may have some overlap. The grant is intended to serve as a seed for additional funding from other granting agencies and part of the application will need to contain a section where the researchers discuss how they will do this.  In addition, it will be critical for the researcher to suggest how this grant will fit into the strategic goals of the IQSEC2 foundation towards reducing morbidity and developing novel treatments of IQSEC2 mediated disease. Innovative therapies are particularly welcome.

Letter of Interest Deadline: Nov. 3, 2023

Agency Website

Eligibility Requirements

All individuals holding a faculty-level appointment at an academic institution or a senior position at a non-profit institution or foundation are eligible to respond to this RFA. Researchers with no prior experience with IQSEC2 are encouraged to apply. 

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

November 3, 2023